SCHEDULE 13G/A 0001325447-25-000022 0001325447 XXXXXXXX LIVE 2 Common 06/30/2025 0000012208 Bio-Rad Laboratories Inc 090572207 1000 Alfred Nobel Drive, Hercules CA 94547 Rule 13d-1(b) First Eagle Investment Management, LLC DE 2326836.25 0 2528321.43 0 2528321.43 11.4 IA FIRST EAGLE GLOBAL FUND DE 1878739.00 0 1878739.00 0 1878739.00 8.5 IC Bio-Rad Laboratories Inc 1000 Alfred Nobel Drive,, Hercules, US-CA, 94547, US First Eagle Investment Management, LLC | FIRST EAGLE GLOBAL FUND First Eagle Investment Management, LLC - 1345 Avenue of the Americas, New York, 10105, New York, United States | FIRST EAGLE GLOBAL FUND - 1345 Avenue of the Americas, New York, 10105, New York, United States First Eagle Investment Management, LLC - DELAWARE FIRST EAGLE GLOBAL FUND - DELAWARE N IA 2,528,321 11.4 2,326,836 0 2,528,321 0 Y N N Securities reported on this Schedule 13G as being beneficially owned by First Eagle Investment Management, LLC are held by or at the direction of First Eagle Investment Management, LLC and/or one or more of its investment adviser subsidiaries, which may include First Eagle Separate Account Management, LLC, principally on behalf of investment advisory clients, which may include investment companies registered under the Investment Company Act, employee benefit plans, pension funds, other institutional clients, or separate accounts, but sometimes for its own account. First Eagle Investment Management, LLC (FEIM), an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 2,528,321.43 shares, or 11.42% of the common stock believed to be outstanding as a result of acting as investment adviser to various clients. Clients of FEIM have the right to receive and the ultimate power to direct the receipt of dividends from, or the proceeds of the sale of, such securities. The First Eagle Global Fund, a registered investment company for which FEIM acts as investment adviser, may be deemed to beneficially own 1,878,739 of these 2,528,321.43 shares, or 8.48% of the Company's Common Stock. Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. First Eagle Investment Management, LLC David O'Connor 08/06/2025 FIRST EAGLE GLOBAL FUND David O'Connor 08/06/2025